News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Cancer
Study Determines Why Patients With HIV Have Higher Rates of Cancer

After investigating why patients with HIV have higher rates of cancer than the general population, researchers identified how T-cells move and multiply to invade other cells in these patients.

Published
17 December 2018
From
American Journal of Managed Care
Cancer
Exploring why people with HIV have a higher risk of lung cancer

On Dec. 1, the 30th annual World AIDS Day, researchers at Fred Hutchinson Cancer Research Center in Seattle announced the start of a new study with a goal to understand why those who are HIV-positive are at higher risk of lung cancer and develop lung cancer at a younger age.

Published
05 December 2018
From
Fred Hutch News Service
Bad science and bogus treatments
Popular prostate cancer videos on YouTube 'inaccurate and biased'

Researchers viewed the 150 first-listed videos on YouTube for prostate cancer screening and treatment, checking them against standard patient information quality criteria. They found that 77% had errors or bias either in the videos or the comments beneath them. Worryingly, the most popular videos were the ones that scored worst on the quality checks.

Published
30 November 2018
From
NHS Behind the Headlines
Cancer
People with HIV can safely use immunotherapy for cancer

Treatment with an immune checkpoint inhibitor appears to be well tolerated and may work as well for HIV-positive people who have cancer as it does for those

Published
24 October 2018
By
Liz Highleyman
Cancer
Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests

Immunotherapy has been a major breakthrough in oncology -- but little is known about its safety for HIV-positive cancer patients. A study to be presented at the ESMO 2018 Congress in Munich has now provided data to suggest that treatment with PD-1/PD-L-1 immune checkpoint inhibitors, which target the very system affected by the HIV virus, is feasible in this patient population for whom cancer is currently one of the principal cause of mortality.

Published
22 October 2018
From
Eurekalert Inf Dis
Cancer
Anal HPV-16 infection significantly more common in men who have sex with men, especially those living with HIV

Anal infection with HPV-16, the type of human papillomavirus most strongly associated with anal cancer, is most common in HIV-positive gay men, similar between HIV-negative gay

Published
15 October 2018
By
Keith Alcorn
Cancer
HIV and cervical cancer – a perfect storm for women in Africa

Epidemics of HIV and HPV are inherently interconnected, and when they meet in the context of weak health systems, their effects serve to amplify each other.

Published
12 October 2018
From
Avert
Vaccinations and immunisations
US: HPV Vaccine Approved for Women and Men up to Age 45

On October 5, the Food and Drug Administration (FDA) expanded its approval of the Gardasil 9 vaccine, which protects against nine difference strains of human papillomavirus (HPV), to cover women and men ages 27 to 45.

Published
12 October 2018
From
Cancer Health
Cancer
Immunotherapy shows promise as a treatment for HIV-related Kaposi sarcoma

Immunotherapy may be an effective treatment for HIV-related Kaposi sarcoma (KS), according to the results of a small US study published in Cancer Immunology Research. Two-thirds of people

Published
20 September 2018
By
Michael Carter
Cardiovascular disease
HIV/AIDS research yields dividends across medical fields

Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other diseases.

Published
28 August 2018
From
Eurekalert Inf Dis
← Prev1...23456...55Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.